{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:19:22Z","timestamp":1772165962562,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type I endometrial cancer is the most common gynaecological tumour in developed countries and its incidence is increasing also because of population aging. The aim of this work is to test the feasibility and safety of anastrozole as palliative treatment of endometrial cancer in elderly women ineligible for standard surgical treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with histological diagnosis of type I endometrial cancer not suitable for surgical treatment were enrolled in this pilot study. Anastrozole was administered 1\u00a0mg daily orally after performing an accurate clinical and radiological staging. Validated questionnaire and self-reported outcomes were used to evaluate quality of life and compliance during the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eight patients with a mean age of 85 (range 80\u201388\u00a0years) were enrolled. All patients had endometrial cancer confined to the uterus, and none progression of disease was observed during the study period. A partial response to the therapy was reported in seven patients, while one patient had stable disease. Tumour symptoms improvement such as pain, vaginal bleeding and vaginal discomfort was reported. The endometrial thickness after twelve months has showed a reduction of 9.25\u2009\u00b1\u20094.77\u00a0mm. The average follow-up time was 18.25\u00a0months. Four women died for non oncological reasons, none death related to endometrial cancer was reported. Evaluation of symptoms showed a significant reduction of appetite loss and insomnia, while a significant increase of global health status and fatigue was reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our preliminary data suggested that the palliative use of anastrozole may be a suitable therapy for the proper management of early stages endometrial cancer in elderly women not suitable for surgical treatment with good compliance and tolerance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      2013000840. Date of registration: 21\/09\/2013. URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/trials.sanmatteo.loc\">trials.sanmatteo.loc<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-021-00719-0","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T01:06:11Z","timestamp":1612487171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women?"],"prefix":"10.1186","volume":"20","author":[{"given":"Barbara","family":"Gardella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-607X","authenticated-orcid":false,"given":"Mattia","family":"Dominoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bogliolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Cassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia Vittoria","family":"Carletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"De Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsenio","family":"Spinillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"719_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"719_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejso.2015.11.001","volume":"42","author":"C Bourgin","year":"2016","unstructured":"Bourgin C, Saidani M, Poupon C, Cauchois A, Foucher F, Leveque J, Lavoue V. Endometrial cancer in elderly women: which disease, which surgical management?. A systematic review of the literature. Eur J Surg Oncol. 2016;42:166\u201375.","journal-title":"Eur J Surg Oncol"},{"key":"719_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ctrv.2016.08.007","volume":"50","author":"L Dumas","year":"2016","unstructured":"Dumas L, Ring A, Butler J, Kalsi T, Harari D, Banerjee S. Improving outcomes for older women with gynaecological malignancies. Cancer Treat Rev. 2016;50:99\u2013108.","journal-title":"Cancer Treat Rev"},{"issue":"suppl 6","key":"719_CR4","doi-asserted-by":"publisher","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","volume":"24","author":"N Colombo","year":"2013","unstructured":"Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, Sessa C, ESMO Guidelines Working Group. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(suppl 6):vi33-38.","journal-title":"Ann Oncol"},{"key":"719_CR5","first-page":"468","volume":"93","author":"MM Braun","year":"2013","unstructured":"Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and management of endometrial cancer. Am Fam Physician. 2013;93:468\u2013674.","journal-title":"Am Fam Physician"},{"key":"719_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/AOG.0b013e3182605bf1","volume":"120","author":"JI Sorosky","year":"2012","unstructured":"Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012;120:383\u201397.","journal-title":"Obstet Gynecol"},{"key":"719_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics. CA. Cancer J Clin. 2013;63:11\u201330.","journal-title":"Cancer J Clin"},{"key":"719_CR8","first-page":"1075","volume":"80","author":"EM Buchanan","year":"2009","unstructured":"Buchanan EM, Weinstein LC, Hillson C. Endometrial cancer. Am Fam Physician. 2009;80:1075\u201380.","journal-title":"Am Fam Physician"},{"key":"719_CR9","doi-asserted-by":"publisher","first-page":"d3954","DOI":"10.1136\/bmj.d3954","volume":"343","author":"S Saso","year":"2011","unstructured":"Saso S, Chatterjee J, Georgiou E, Ditri AM, Smith JR, Ghaem-Maghami S. Endometrial cancer. BMJ. 2011;343:d3954.","journal-title":"BMJ"},{"key":"719_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/CEJ.0b013e32811080ce","volume":"17","author":"MC Boruban","year":"2008","unstructured":"Boruban MC, Altundag K, Kilic GS, Blankstein J. From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. Eur J Cancer Prev. 2008;17:133\u20138.","journal-title":"Eur J Cancer Prev"},{"key":"719_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1210\/jcem-49-6-905","volume":"49","author":"PC MacDonald","year":"1979","unstructured":"MacDonald PC, Madden JD, Brenner PF, Wilson JD, Siiteri PK. Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab. 1979;49:905\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"719_CR12","first-page":"1831","volume":"79","author":"SE Bulun","year":"1994","unstructured":"Bulun SE, Economos K, Miller D, Simpson ER. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab. 1994;79:1831\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"719_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1210\/jcem-36-2-207","volume":"36","author":"JM Grodin","year":"1973","unstructured":"Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973;36:207\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"719_CR14","volume-title":"The NHS cancer plan: A plan for investment, A plan for reform","author":"Department of Health","year":"2000","unstructured":"Department of Health. The NHS cancer plan: A plan for investment, A plan for reform. London: Department of Health; 2000."},{"issue":"Supple 4","key":"719_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0959-8049(01)00448-8","volume":"38","author":"P Fayers","year":"2002","unstructured":"Fayers P, Bottomley A, EORTC Quality of Life Group, Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer. 2002;38(Supple 4):125\u201333.","journal-title":"Eur J Cancer"},{"key":"719_CR16","volume-title":"WHO handbook for reporting results of cancer treatments","author":"World Health Organization","year":"1979","unstructured":"World Health Organization. WHO handbook for reporting results of cancer treatments. Geneva: WHO; 1979."},{"key":"719_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"KY Liang","year":"1986","unstructured":"Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13\u201322.","journal-title":"Biometrika"},{"key":"719_CR18","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/cncr.11745","volume":"98","author":"M Baum","year":"2003","unstructured":"Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T. ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists\u2019 Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer. 2003;98:1802\u201310.","journal-title":"Cancer"},{"key":"719_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00404-015-3974-9","volume":"293","author":"S Bogliolo","year":"2016","unstructured":"Bogliolo S, Gardella B, Dominoni M, Musacchi V, Cassani C, Zanellini F, De Silvestri A, Gaggero CR, Babilonti L, Spinillo A. Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma. Arch Gynecol Obstet. 2016;293:701\u20138.","journal-title":"Arch Gynecol Obstet"},{"key":"719_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2014.04.060","volume":"134","author":"C Gao","year":"2014","unstructured":"Gao C, Wang Y, Tian W, Zhu Y, Xue F. The therapeutic significance of aromatase inhibitors in endometrial carcinoma. Gynecol Oncol. 2014;134:190\u20135.","journal-title":"Gynecol Oncol"},{"key":"719_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ygyno.2013.09.023","volume":"131","author":"A Thangavelu","year":"2013","unstructured":"Thangavelu A, Hewitt MJ, Quinton ND, Duffy SR. Neoadjuvant treatment of endometrial cancer using anastrozole: a randomised pilot study. Gynecol Oncol. 2013;131:613\u20138.","journal-title":"Gynecol Oncol"},{"key":"719_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.breast.2008.05.008","volume":"17","author":"M Valenzano Menada","year":"2008","unstructured":"Valenzano Menada M, Costantini S, Moioli M, Bogliolo S, Papadia A, Ferrero S, Dugnani MC. Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole. Breast. 2008;17:631\u20136.","journal-title":"Breast"},{"key":"719_CR23","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/pon.5151","volume":"28","author":"J Weis","year":"2019","unstructured":"Weis J, Wirtz MA, Tomaszewski KA, Hammerlid E, Arraras JI, Conroy T, Lanceley A, Schmidt H, Singer S, Pinto M, El-Din MA, Compter I, Holzner B, Hofmeister D, Chie WC, Harle A, Flechtner HH, Bottomley A, EORTC Quality of Life Group. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): results from the international psychometric validation. Psychooncology. 2019;28:1753\u201361.","journal-title":"Psychooncology"},{"key":"719_CR24","doi-asserted-by":"crossref","unstructured":"Jing MJ, Wang JJ, Lin WQ, Lei YX, Wang PX. A community-based cross-sectional study of fatigue in middle-aged and elderly women. J Psychosom Res. 2015;79:288\u201394.","DOI":"10.1016\/j.jpsychores.2015.05.009"},{"key":"719_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/00006254-199505000-00026","volume":"50","author":"J Yu Song","year":"1995","unstructured":"Yu Song J, Fraser IS. Effects of progestangens on human endometrium. Obstet Gynecol Sur. 1995;50:385\u201394.","journal-title":"Obstet Gynecol Sur"},{"key":"719_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1200\/JCO.1996.14.2.357","volume":"14","author":"SS Lentz","year":"1996","unstructured":"Lentz SS, Brady MF, Major FJ, Reid GC, Soper JT. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol. 1996;14:357\u201361.","journal-title":"J Clin Oncol"},{"key":"719_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/beog.2000.0189","volume":"15","author":"E Podczaski","year":"2001","unstructured":"Podczaski E, Mortel. Hormonal treatment of endometrial cancer: past, present and future. Best Pract Res Clin Obstet Gynaecol. 2001;15:469\u201389.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"719_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bpobgyn.2007.08.003","volume":"22","author":"A Garrett","year":"2008","unstructured":"Garrett A, Quinn MA. Hormonal therapies and gynaecological cancers. Best Pract Res Clin Obstet Gynaecol. 2008;22:407\u201321.","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00719-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12904-021-00719-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-021-00719-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T01:06:48Z","timestamp":1612487208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-021-00719-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1186\/s12904-021-00719-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21712\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21712\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21712\/v3","asserted-by":"object"}]},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The informed consent obtained was written.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}